Galectin Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GALT and other ETFs, options, and stocks.About GALT
Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments.
CEOJoel Lewis
CEOJoel Lewis
Employees15
Employees15
HeadquartersNorcross, Georgia
HeadquartersNorcross, Georgia
Founded2000
Founded2000
Employees15
Employees15
GALT Key Statistics
Market cap419.14M
Market cap419.14M
Price-Earnings ratio-10.57
Price-Earnings ratio-10.57
Dividend yield—
Dividend yield—
Average volume639.82K
Average volume639.82K
High today$6.40
High today$6.40
Low today$5.54
Low today$5.54
Open price$5.72
Open price$5.72
Volume760.70K
Volume760.70K
52 Week high$6.66
52 Week high$6.66
52 Week low$0.726
52 Week low$0.726
Stock Snapshot
Galectin Therapeutics(GALT) stock is priced at $6.30, giving the company a market capitalization of 419.14M. It carries a P/E multiple of -10.57.
During the trading session on 2025-12-13, Galectin Therapeutics(GALT) shares reached a daily high of $6.40 and a low of $5.54. At a current price of $6.30, the stock is +13.7% higher than the low and still -1.6% under the high.
Trading volume for Galectin Therapeutics(GALT) stock has reached 760.7K, versus its average volume of 639.82K.
The stock's 52-week range extends from a low of $0.73 to a high of $6.66.
The stock's 52-week range extends from a low of $0.73 to a high of $6.66.
People also own
Based on the portfolios of people who own GALT. This list is generated using Robinhood data, and it’s not a recommendation.